Reviews in Endocrine and Metabolic Disorders

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Reviews in Endocrine and Metabolic Disorders is a journal published by Springer Science+Business Media in Netherlands. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,990 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
1389-9155 · 1573-2606
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
4,990 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2000-01-01
Indexing
MEDLINE
APC
4,990 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
82 days received→accepted — computed from PubMed (n=74)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1258

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

127

i10-index

955

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
96%
ORCID iDs in current deposits
59%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
100940588
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Growth Hormone and Insulin-like Growth Factors
  • Growth Hormone and Insulin-like Growth Factors
  • Diet and metabolism studies
  • Diet and metabolism studies
  • Pituitary Gland Disorders and Treatments
  • Pituitary Gland Disorders and Treatments
  • Adipose Tissue and Metabolism
  • Adipose Tissue and Metabolism
Show all subjects (50)
  • Pancreatic function and diabetes
  • Pancreatic function and diabetes
  • Regulation of Appetite and Obesity
  • Regulation of Appetite and Obesity
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Vitamin D Research Studies
  • Vitamin D Research Studies
  • Diabetes and associated disorders
  • Adrenal Hormones and Disorders
  • Adrenal Hormones and Disorders
  • Diabetes and associated disorders
  • Adipokines, Inflammation, and Metabolic Diseases
  • Adipokines, Inflammation, and Metabolic Diseases
  • Thyroid Disorders and Treatments
  • Diabetes Management and Research
  • Thyroid Disorders and Treatments
  • Adrenal and Paraganglionic Tumors
  • Diabetes Management and Research
  • Adrenal and Paraganglionic Tumors
  • Hormonal and reproductive studies
  • Hormonal and reproductive studies
  • Metabolism, Diabetes, and Cancer
  • Metabolism, Diabetes, and Cancer
  • Diabetes Treatment and Management
  • Diabetes Treatment and Management
  • Hormonal Regulation and Hypertension
  • Hormonal Regulation and Hypertension
  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid Cancer Diagnosis and Treatment
  • Bone health and osteoporosis research
  • Bone health and treatments
  • Bone health and osteoporosis research
  • Sexual Differentiation and Disorders
  • Sexual Differentiation and Disorders
  • Bone health and treatments
  • Neuroblastoma Research and Treatments
  • Neuroblastoma Research and Treatments
  • Birth, Development, and Health
  • Estrogen and related hormone effects
  • Estrogen and related hormone effects
  • Birth, Development, and Health

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: